Industry News
Biotechnology Industry News
Eisai wraps filing for Biogen-partnered Aduhelm follow-up, hoping to regain ‘credibility and trust’
Eisai wraps filing for Biogen-partnered Aduhelm follow-up, hoping to regain 'credibility and trust' aarmstrong Mon, 05/09/2022 - 15:54
More Moma: $150M series B will push precision cancer drugs to clinic by 2024
More Moma: $150M series B will push precision cancer drugs to clinic by 2024 gmasson Mon, 05/09/2022 - 15:13
Sesen Bio reports progress with regulators as it preps for new cancer trial, but issues remain
Sesen Bio reports progress with regulators as it preps for new cancer trial, but issues remain mbayer Mon, 05/09/2022 - 11:01
Investors take root in Aspen Neuroscience’s customized cell therapy as $147.5M round closes
Investors take root in Aspen Neuroscience’s customized cell therapy as $147.5M round closes gmasson Mon, 05/09/2022 - 10:45
LogicBio’s sun and shares rise again after FDA releases clinical hold on pediatric genome editing therapy
LogicBio's sun and shares rise again after FDA releases clinical hold on pediatric genome editing therapy aarmstrong Mon, 05/09/2022 - 10:11
J&J axes Bavarian Nordic pact for HPV and Hep B vax, keeps two other programs
J&J axes Bavarian Nordic pact for HPV and Hep B vax, keeps two other programs mbayer Mon, 05/09/2022 - 09:53
J&J axes Bavarian Nordic pact for HPV and hep B vax, keeps 2 other programs
J&J axes Bavarian Nordic pact for HPV and hep B vax, keeps 2 other programs mbayer Mon, 05/09/2022 - 09:53
Investors flip-flop on Nykode’s cancer vaccine data drop
Investors flip-flop on Nykode's cancer vaccine data drop ntaylor Mon, 05/09/2022 - 06:36
Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect
Another Oxurion eye disease drug flunks phase 2, leaving biotech all-in on last prospect ntaylor Mon, 05/09/2022 - 05:31
UPDATE: VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety
UPDATE: VistaGen says regulators couldn’t sniff out abuse potential of its nasal spray for social anxiety mbayer Fri, 05/06/2022 - 10:32
With Sarepta in its sights, PepGen prices IPO to fund DMD trials
With Sarepta in its sights, PepGen prices IPO to fund DMD trials ntaylor Fri, 05/06/2022 - 07:16
Bye-bye: Xencor culls 2 bispecifics after early-phase solid tumor data underwhelm
Bye-bye: Xencor culls 2 bispecifics after early-phase solid tumor data underwhelm ntaylor Fri, 05/06/2022 - 06:14
Orion aims to challenge Vertex with new pain management licensing deal
Orion aims to challenge Vertex with new pain management licensing deal jwaldron Fri, 05/06/2022 - 06:02
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs
After layoffs, BridgeBio turns to dealmaking for up to 6 drugs gmasson Thu, 05/05/2022 - 14:20
Chutes & Ladders—Biogen CEO Vounatsos steps down amid company overhaul following Aduhelm blunder
Chutes & Ladders—Biogen CEO Vounatsos steps down amid company overhaul following Aduhelm blunder mbayer Thu, 05/05/2022 - 13:26
Intellia puts pedal to the metal as 3 new candidates prepped for clinic
Intellia puts pedal to the metal as 3 new candidates prepped for clinic aarmstrong Thu, 05/05/2022 - 10:26
BioCryst’s voluntary pause turns FDA-hold as investigation reveals likely culprit behind safety signals
BioCryst's voluntary pause turns FDA-hold as investigation reveals likely culprit behind safety signals mbayer Thu, 05/05/2022 - 10:21
Big pharma resisting temptation for biotech M&A spree until prices drop further
Big pharma resisting temptation for biotech M&A spree until prices drop further jwaldron Thu, 05/05/2022 - 09:53
Bavarian Nordic’s COVID-19 vaccine holds up against omicron in phase 2, fueling pivotal booster push
Bavarian Nordic's COVID-19 vaccine holds up against omicron in phase 2, fueling pivotal booster push ntaylor Thu, 05/05/2022 - 08:54
Jazz flexes deal chops, paying Sumitomo $50M for ex-Asia rights to early-phase narcolepsy prospect
Jazz flexes deal chops, paying Sumitomo $50M for ex-Asia rights to early-phase narcolepsy prospect ntaylor Thu, 05/05/2022 - 08:05